论文部分内容阅读
本研究评估多沙唑嗪长期(54周)治疗轻、中度原发性高血压(坐位或立位舒张压为12.7—15.2kPa)的效果及安全性。153例患者完成14周初期试验,其中61例进入40周
This study evaluated the efficacy and safety of doxazosin for long-term (54 weeks) treatment of mild to moderate essential hypertension (sitting or standing diastolic pressure of 12.7-15.2 kPa). Fifty-three patients completed the initial 14-week trial, 61 of which entered for 40 weeks